BNP PARIBAS FINANCIAL MARKETS - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 101 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.43 and the average weighting 0.3%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$103,693,000
-9.1%
30,498
+0.5%
0.00%
Q2 2018$114,105,000
+24.7%
30,347
+35.6%
0.00%
Q1 2018$91,506,000
-8.9%
22,373
+3.6%
0.00%
Q4 2017$100,445,000
+47.3%
21,601
+124.9%
0.00%
Q3 2017$68,181,000
-7.1%
9,603
-5.4%
0.00%
Q2 2017$73,399,000
+627.4%
10,152
+519.8%
0.00%
Q1 2017$10,090,000
-69.5%
1,638
-70.9%
0.00%
Q4 2016$33,033,000
-7.5%
5,637
-16.2%
0.00%
Q3 2016$35,715,000
+77.9%
6,726
+121.8%
0.00%
Q2 2016$20,078,000
-83.2%
3,033
-87.2%
0.00%
Q4 2015$119,504,000
+58.5%
23,664
+10.5%
0.00%
Q3 2015$75,398,000
-12.3%
21,420
+148.5%
0.00%
Q2 2015$86,008,000
+238.8%
8,618
+332.2%
0.00%
Q1 2015$25,384,000
-69.4%
1,994
-67.0%
0.00%
Q3 2014$83,064,000
+2009.8%
6,041
+2259.8%
0.00%
Q2 2014$3,937,000
+122.2%
256
+113.3%
0.00%
Q1 2014$1,772,000
-87.1%
120
-88.7%
0.00%
Q4 2013$13,727,000
-94.0%
1,060
-95.3%
0.00%
Q3 2013$227,318,000
+5.0%
22,529
-22.3%
0.00%
Q2 2013$216,496,00028,9820.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q2 2013
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,312,006$22,357,00015.70%
VHCP Management, LLC 1,000,273$17,045,0008.86%
HARVEY CAPITAL MANAGEMENT INC 915,800$15,605,0006.22%
Baupost Group 6,310,850$107,537,0002.60%
SECTORAL ASSET MANAGEMENT INC 3,537,590$60,281,0002.48%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 587,504$10,011,0002.31%
Knoll Capital Management, LLC 200,000$3,408,0001.76%
Camber Capital Management LP 1,250,000$21,300,0001.67%
NORTHPOINTE CAPITAL LLC 877,875$14,958,0001.52%
DAFNA Capital Management LLC 100,000$1,704,0001.46%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders